Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access

Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access 17-Aug-2022 / 07:00 CET/CEST Release of an ad hoc announcement

Related Keywords

Geneva ,Genè ,Switzerland ,Secheron ,Switzerland General ,United States ,Swiss ,Anthony Kim ,Michael Miller ,Jack Weinstein ,Advita Lifescience Gmb ,Relief Therapeutics Holding Sa Key ,Patient Services Southeast At Shire ,Pharma Research ,Louis Christian College ,Us Commercial Team ,Swiss Exchange ,Rx Communications Group ,Exchange Commission ,Payer Account Lead At Mirum Pharmaceuticals Inc ,Relief Therapeutics Holding ,News Service ,Mcneese State University ,Abbott Laboratories ,Mirum Pharmaceuticals Inc ,Therapeutics Appoints David Mccullough ,Market Access ,Bolster Relief ,David Mccullough ,Senior Director ,Senior Vice President ,Mirum Pharmaceuticals ,Novartis Gene Therapies ,Spark Therapeutics ,National Account Director ,Payer Account Lead ,Director National Accounts ,Value Based Agreements ,Patient Access Liaison ,Associate Director ,Patient Services Southeast ,Institutional Specialty Manager ,Territory Manager ,Public Relations ,United States Coast ,License Agreement ,Acer Therapeutics ,Maple Syrup Urine Disease ,Advita Lifescience Gmbh ,Financial Officer ,Adhoc ,Relief ,Herapeutics ,Molding ,Ppoints ,David ,Mccullough ,Head ,Market ,Access ,